Listed

Pediatrix Medical Group, Inc.

MDNYSECIK 893949HealthcareFiscal year ends Dec 31

Reports and events: 259 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Pediatrix Medical Group, Inc., Reports and events
FiledFormWhat it isAccession number
2023-03-0817:15 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-006748
2023-02-1707:00 ET10-KAnnual reportPeriod 2022-12-310000950170-23-003127
2023-02-1706:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-003125
2023-01-2017:24 ETSC 13D/AOwnership report, active investor, amended0000921895-23-000157
2022-12-1607:17 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-026632
2022-12-0217:25 ETSC 13D/AOwnership report, active investor, amended0000921895-22-003156
2022-11-0307:00 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-021526
2022-11-0306:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-021516
2022-09-2316:31 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-250187
2022-08-0407:22 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-014473
2022-08-0407:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-014467
2022-06-2107:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-011839
2022-05-1717:01 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0000950170-22-010201
2022-04-2807:00 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-006427
2022-04-2806:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-006426
2022-04-0117:00 ETDEF 14AProxy statementPeriod 2022-05-120001193125-22-093819
2022-02-2517:01 ET8-K5.02 Departure or appointment of officers or directors0000950170-22-002114
2022-02-1707:02 ET10-KAnnual reportPeriod 2021-12-310000950170-22-001387
2022-02-1706:52 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-001386
2022-02-1407:01 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-001148
2021-11-1917:26 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-21-004821
2021-10-2807:01 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-002406
2021-10-2806:49 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-002405
2021-08-3107:30 ETSC 13D/AOwnership report, active investor, amended0001193805-21-001252
2021-08-2716:31 ET8-K8.01 Other events0000950170-21-001577
2021-08-0607:05 ET10-QQuarterly reportPeriod 2021-06-300000950170-21-000978
2021-08-0606:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-238355
2021-05-1716:24 ET8-K1.01 Entry into a material agreement0001193125-21-163735
2021-05-1416:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-21-161991
2021-05-0707:00 ET10-QQuarterly reportPeriod 2021-03-310001193125-21-154019
2021-05-0706:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-154005
2021-03-2316:18 ETDEF 14AProxy statementPeriod 2021-05-120001193125-21-091206
2021-02-1807:00 ET10-KAnnual reportPeriod 2020-12-310001193125-21-047064
2021-02-1806:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-047053
2020-12-2116:25 ET8-K2.01 Completion of an acquisition or disposition; 2.04 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-323140
2020-11-2416:17 ET8-K8.01 Other events0001193125-20-302610
2020-11-0607:01 ET10-QQuarterly reportPeriod 2020-09-300001193125-20-287356
2020-11-0606:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-287348
2020-09-2917:10 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-257929
2020-09-1521:11 ET8-K1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-20-245502
2020-09-1006:45 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-242587
2020-08-2506:55 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-229109
2020-07-3007:00 ET10-QQuarterly reportPeriod 2020-06-300001193125-20-203325
2020-07-3006:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-203317
2020-07-2816:18 ETDEF 14AProxy statementPeriod 2020-09-090001193125-20-200999
2020-07-1317:25 ETSC 13D/AOwnership report, active investor, amended0000921895-20-001971
2020-07-1309:10 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-191602
2020-06-1521:27 ET8-K8.01 Other events0001193125-20-168098
2020-06-0506:50 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-161340
2020-05-1509:00 ETSC 13D/AOwnership report, active investor, amended0001193805-20-000593

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:14 ET. Listed shows no prices and gives no investment advice.